SIGMAXIN digoxin 250microgram tablet blister pack ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

sigmaxin digoxin 250microgram tablet blister pack

aspen pharma pty ltd - digoxin, quantity: 250 microgram - tablet, uncoated - excipient ingredients: magnesium stearate; rice starch; lactose monohydrate; oxidised maize starch; hydrolysed maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

SIGMAXIN PG digoxin 62.5microgram tablet bottle ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

sigmaxin pg digoxin 62.5microgram tablet bottle

aspen pharma pty ltd - digoxin, quantity: 0.0625 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; rice starch; magnesium stearate; hydrolysed maize starch; povidone; indigo carmine; oxidised maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

MAXI-OTIC- gentamicin sulfate, mometasone furoate monohydrate, and clotrimazole suspension संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

maxi-otic- gentamicin sulfate, mometasone furoate monohydrate, and clotrimazole suspension

butler animal health supply - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), mometasone furoate monohydrate (unii: mtw0weg809) (mometasone - unii:8hr4qj6dw8), clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - f-27078915 nada #141-177, approved by fda. product information veterinary for otic use in dogs only caution federal law restricts this drug to use by or on the order of a licensed veterinarian. keep this and all drugs out of the reach of children. indications maxi-otic otic suspension is indicated for the treatment of otitis externa in dogs caused by susceptible strains of yeast (malassezia pachydermatis ) and bacteria (pseudomonas spp. [including p. aeruginosa ], coagulasepositive staphylococci, enterococcus faecalis, proteus mirabilis , and beta-hemolytic streptococci). contraindications if hypersensitivity to any of the components occurs, treatment should be discontinued and appropriate therapy instituted. concomitant use of drugs known to induce ototoxicity should be avoided. do not use in dogs with known perforation of eardrums.

MAXI-TRANS ORAL REHYDRATION THERAPY ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

maxi-trans oral rehydration therapy

maxi-minerals pty ltd - glucose | potassium chloride | sodium bicarbonate | sodium chloride - nutrition & metabolism - calf - up to 4 weeks old | cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow - dehydration | scours | selenium responsive scours

Maxillofacial bone separator ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

maxillofacial bone separator

biomedent pty ltd - 64306 - maxillofacial bone separator - a hand-held, manual, one-piece surgical instrument intended to split/force apart bones in the face, mouth and/or jaws (e.g., palate, mandibular inferior border) during maxillofacial surgery (e.g., sagittal split osteotomy procedure); it is not designed to cut or shape bone (i.e., not an osteotome). it is a metal instrument typically available as: 1) a curved shaft with a handle and a blade at the distal working end; or 2) a hinged device with two blades at the distal working end and a spring handle. this is a reusable device.

PARACOX-5 ANTICOCCIDIAL VACCINE FOR CHICKENS ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

paracox-5 anticoccidial vaccine for chickens

intervet australia pty limited - eimeria acervulina hp; eimeria maxima cp; eimeria maxima mfp; eimeria mitis hp; eimeria tenella hp - misc. vaccines or anti sera - eimeria acervulina hp vaccine-general active 500.0 ooc/dose; eimeria maxima cp vaccine-general active 200.0 ooc/dose; eimeria maxima mfp vaccine-general active 100.0 ooc/dose; eimeria mitis hp vaccine-general active 1000.0 ooc/dose; eimeria tenella hp vaccine-general active 500.0 ooc/dose - immunotherapy - poultry broilers (meat for human consum) | chickens | chooks | meat birds - coccidiosis - see label for causes | eimeria acervulina | eimeria arloingi | eimeria bovis | eimeria brunetti | eimeria christenseni | eimeria maxima | eimeria mitis | eimeria mivati | eimeria necatrix | eimeria ninakohlyakimovae | eimeria praecox | eimeria tenella | eimeria zuernii

Fortegra Each dose contains:   Eimeria acervulina (051491ac Strain) .... 2 600 oocysts Eimeria maxima (071395MA Strain) ..... >200 oocysts Eimeria maxima (MFP Strain) ................ 100 oocysts Eimeria mivati (05289MI Strain) ......... > 400 oocysts Eimeria tenella (060691TE Strain) ....... 2 200 oocysts Suspension (Oral/Aerosol) फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

fortegra each dose contains: eimeria acervulina (051491ac strain) .... 2 600 oocysts eimeria maxima (071395ma strain) ..... >200 oocysts eimeria maxima (mfp strain) ................ 100 oocysts eimeria mivati (05289mi strain) ......... > 400 oocysts eimeria tenella (060691te strain) ....... 2 200 oocysts suspension (oral/aerosol)

msd animal health (phils.), inc. - live eimeria acervulina , e. maxima , e. mivati , e. tenella oocyst vaccine (vet.) - suspension (oral/aerosol) - each dose contains: eimeria acervulina (051491ac strain) .... 2 600 oocysts eimeria maxima (071395ma strain) ..... >200 oocysts eimeria maxima (mfp strain) ................ 100 oocysts eimeria mivati (05289mi strain) ......... > 400 oocysts eimeria tenella (060691te strain) ....... 2 200 oocysts

Evant Formulation:   Each 7 uL (dose) of undiluted vaccine contains:   Eimeria acervulina (003 strain)- 332-450 * Eimeria mitis (006 strain)-293-397 * Eimeria praecox (007 strain)-293-397 * Eimeria tenella (004 strain)-276-374 * Eimeria maxima (013 strain)-196-265 *   * Number of sporulated cocysts at the time of blanding in vitro. Suspension   (Oral/Aerosol) फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

evant formulation: each 7 ul (dose) of undiluted vaccine contains: eimeria acervulina (003 strain)- 332-450 * eimeria mitis (006 strain)-293-397 * eimeria praecox (007 strain)-293-397 * eimeria tenella (004 strain)-276-374 * eimeria maxima (013 strain)-196-265 * * number of sporulated cocysts at the time of blanding in vitro. suspension (oral/aerosol)

hipra philippines, inc.; distributor: hipra philippines, inc. - live attenuated eimeria acervulina, eimeria mitis , eimeria praecox , eimeria tenella , eimeria maxima vaccine (vet.) - suspension (oral/aerosol) - formulation: each 7 ul (dose) of undiluted vaccine contains: eimeria acervulina (003 strain)- 332-450 * eimeria mitis (006 strain)-293-397 * eimeria praecox (007 strain)-293-397 * eimeria tenella (004 strain)-276-374 * eimeria maxima (013 strain)-196-265 * * number of sporulated cocysts at the time of blanding in vitro.